ArticleCureus2025

Real-Life Experience of HER2 (Human Epidermal Growth Factor Receptor 2)-Positive Advanced Breast Cancer Patients Treated With T-DXd (Trastuzumab Deruxtecan): A Multicentric Portuguese Study.

Rita Bizarro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.